Last reviewed · How we verify

Geref (sermorelin)

Emd Serono · FDA-approved active Quality 35/100

Geref (generic name: sermorelin) is a sermorelin drug developed by Emd Serono. It is currently FDA-approved (first approved 1990) for Diagnostic Test for Growth Hormone Secretion, Pituitary dwarfism.

Geref (sermorelin) is a small molecule drug that targets the growth hormone-releasing hormone receptor. Originally developed by a pharmaceutical company, it is currently owned by Emd Serono and was FDA approved in 1990 for diagnostic testing of growth hormone secretion and treatment of pituitary dwarfism. As an off-patent medication with no active Orange Book patents, Geref is not commercially available as a generic. Key safety considerations include its short half-life of 0.19 hours. Geref is used to stimulate growth hormone release in the body.

At a glance

Generic namesermorelin
SponsorEmd Serono
Drug classsermorelin
TargetGrowth hormone-releasing hormone receptor
Therapeutic areaHematology
PhaseFDA-approved
First approval1990

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Geref

What is Geref?

Geref (sermorelin) is a sermorelin drug developed by Emd Serono, indicated for Diagnostic Test for Growth Hormone Secretion, Pituitary dwarfism.

What is Geref used for?

Geref is indicated for Diagnostic Test for Growth Hormone Secretion, Pituitary dwarfism.

Who makes Geref?

Geref is developed and marketed by Emd Serono (see full Emd Serono pipeline at /company/unknown).

What is the generic name of Geref?

sermorelin is the generic (nonproprietary) name of Geref.

What drug class is Geref in?

Geref belongs to the sermorelin class. See all sermorelin drugs at /class/sermorelin.

When was Geref approved?

Geref was first approved on 1990.

What development phase is Geref in?

Geref is FDA-approved (marketed).

What does Geref target?

Geref targets Growth hormone-releasing hormone receptor and is a sermorelin.

Related